Trial intelligence / Profile preview

Leptin in Fasting Humans

NCT00140231Phase 2Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Oct 2002
Primary completion
Mar 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of metreleptin in obesity, Malnutrition, sponsored by Beth Israel Deaconess Medical Center. Started Oct 2002; status: completed.

02

Drugs

metreleptin
03

Conditions

obesityMalnutrition

Beyond the preview

Go deeper on NCT00140231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00140231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call